BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Techniques

Beam co-founder describes base editors with reduced RNA editing

Karen Tkach Tuzman
September 12, 2019 11:14 PM UTC

TECHNOLOGY: Gene therapy...

BCIQ Company Profiles

Beam Therapeutics Inc.

Massachusetts General Hospital

BCIQ Target Profiles

Apoliprotein B mRNA editing enzyme catalytic subunit 1 (APOBEC1)

BCIQ Company Profiles

Beam Therapeutics Inc.

Massachusetts General Hospital

BCIQ Target Profiles

Apoliprotein B mRNA editing enzyme catalytic subunit 1 (APOBEC1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS